Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Affirm Holdings, Inc. stock logo
AFRM
Affirm
$50.99
-3.0%
$60.63
$22.25
$82.53
$16.20B3.638.04 million shs4.38 million shs
ANSYS, Inc. stock logo
ANSS
ANSYS
$325.32
-0.1%
$336.88
$289.82
$363.03
$28.51B1.11512,371 shs136,535 shs
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
$40.93
-4.0%
$43.16
$36.52
$73.09
$3.51B1.771.53 million shs864,853 shs
MongoDB, Inc. stock logo
MDB
MongoDB
$198.89
+0.7%
$250.11
$173.13
$387.19
$14.84B1.31.70 million shs783,061 shs
UiPath Inc. stock logo
PATH
UiPath
$11.37
+1.4%
$13.07
$9.50
$23.35
$6.25B19.57 million shs3.44 million shs
Synopsys, Inc. stock logo
SNPS
Synopsys
$456.53
-0.3%
$490.60
$425.73
$624.80
$70.59B1.161.02 million shs338,628 shs
Technology Select Sector SPDR Fund stock logo
XLK
Technology Select Sector SPDR Fund
$218.08
+0.2%
$227.84
$190.75
$243.14
$67.72B1.144.96 million shs2.50 million shs
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Affirm Holdings, Inc. stock logo
AFRM
Affirm
+5.29%+9.55%-23.36%-20.27%+45.78%
ANSYS, Inc. stock logo
ANSS
ANSYS
+0.47%+0.24%-2.54%-4.99%-6.73%
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
+3.40%-0.47%-11.04%+4.10%-40.48%
MongoDB, Inc. stock logo
MDB
MongoDB
+2.57%+2.29%-27.73%-18.73%-44.45%
UiPath Inc. stock logo
PATH
UiPath
+3.61%+3.71%-16.67%-14.74%-51.26%
Synopsys, Inc. stock logo
SNPS
Synopsys
+2.04%+0.94%-3.59%-8.48%-22.96%
Technology Select Sector SPDR Fund stock logo
XLK
Technology Select Sector SPDR Fund
+1.72%+1.02%-7.34%-9.52%+3.68%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Affirm Holdings, Inc. stock logo
AFRM
Affirm
3.9522 of 5 stars
4.35.00.00.01.73.30.6
ANSYS, Inc. stock logo
ANSS
ANSYS
2.633 of 5 stars
1.23.00.04.12.72.50.0
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
2.8875 of 5 stars
4.21.00.00.01.53.30.6
MongoDB, Inc. stock logo
MDB
MongoDB
4.6693 of 5 stars
4.45.00.03.13.42.50.0
UiPath Inc. stock logo
PATH
UiPath
2.6994 of 5 stars
3.02.00.00.02.74.20.6
Synopsys, Inc. stock logo
SNPS
Synopsys
4.9048 of 5 stars
4.53.00.03.03.52.52.5
Technology Select Sector SPDR Fund stock logo
XLK
Technology Select Sector SPDR Fund
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Affirm Holdings, Inc. stock logo
AFRM
Affirm
2.67
Moderate Buy$69.7636.83% Upside
ANSYS, Inc. stock logo
ANSS
ANSYS
2.33
Hold$352.508.36% Upside
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
2.48
Hold$73.1178.61% Upside
MongoDB, Inc. stock logo
MDB
MongoDB
2.77
Moderate Buy$320.7061.25% Upside
UiPath Inc. stock logo
PATH
UiPath
2.00
Hold$13.6219.82% Upside
Synopsys, Inc. stock logo
SNPS
Synopsys
2.92
Moderate Buy$638.5839.88% Upside
Technology Select Sector SPDR Fund stock logo
XLK
Technology Select Sector SPDR Fund
2.73
Moderate Buy$218.600.24% Upside

Current Analyst Ratings Breakdown

Latest ANSS, SNPS, XLK, MDB, AFRM, CRSP, and PATH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/24/2025
Affirm Holdings, Inc. stock logo
AFRM
Affirm
Seaport Res Ptn
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
3/20/2025
Affirm Holdings, Inc. stock logo
AFRM
Affirm
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform$69.00
3/19/2025
Affirm Holdings, Inc. stock logo
AFRM
Affirm
Compass Point
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$61.00 ➝ $64.00
3/18/2025
Affirm Holdings, Inc. stock logo
AFRM
Affirm
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$90.00 ➝ $56.00
3/14/2025
UiPath Inc. stock logo
PATH
UiPath
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetMarket Perform ➝ Market Perform$16.00 ➝ $11.50
3/13/2025
UiPath Inc. stock logo
PATH
UiPath
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector Perform ➝ Sector Perform$16.00 ➝ $13.00
3/13/2025
UiPath Inc. stock logo
PATH
UiPath
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$19.00 ➝ $14.00
3/13/2025
UiPath Inc. stock logo
PATH
UiPath
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSell ➝ Sell$14.00 ➝ $10.00
3/13/2025
UiPath Inc. stock logo
PATH
UiPath
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector Perform ➝ Sector Perform$15.00 ➝ $12.00
3/13/2025
UiPath Inc. stock logo
PATH
UiPath
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetIn-Line ➝ In-Line$16.00 ➝ $12.00
3/13/2025
UiPath Inc. stock logo
PATH
UiPath
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$13.00 ➝ $11.00
(Data available from 3/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Affirm Holdings, Inc. stock logo
AFRM
Affirm
$2.80B5.79N/AN/A$8.78 per share5.81
ANSYS, Inc. stock logo
ANSS
ANSYS
$2.54B11.20$9.92 per share32.81$69.60 per share4.67
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
$35M100.31N/AN/A$22.52 per share1.82
MongoDB, Inc. stock logo
MDB
MongoDB
$2.01B7.38N/AN/A$14.70 per share13.53
UiPath Inc. stock logo
PATH
UiPath
$1.43B4.37N/AN/A$3.54 per share3.21
Synopsys, Inc. stock logo
SNPS
Synopsys
$6.07B11.63$11.83 per share38.60$58.54 per share7.80
Technology Select Sector SPDR Fund stock logo
XLK
Technology Select Sector SPDR Fund
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Affirm Holdings, Inc. stock logo
AFRM
Affirm
-$517.76M-$0.65N/A82.23N/A-7.10%-7.25%-2.02%5/6/2025 (Estimated)
ANSYS, Inc. stock logo
ANSS
ANSYS
$575.69M$6.5549.673.4822.62%12.69%9.65%4/29/2025 (Estimated)
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
-$366.25M-$4.37N/AN/AN/A-981.54%-18.46%-15.79%5/6/2025 (Estimated)
MongoDB, Inc. stock logo
MDB
MongoDB
-$176.60M-$1.78N/AN/AN/A-10.46%-12.22%-5.19%5/29/2025 (Estimated)
UiPath Inc. stock logo
PATH
UiPath
-$89.88M-$0.13N/AN/AN/A-6.49%-4.14%-2.82%5/27/2025 (Estimated)
Synopsys, Inc. stock logo
SNPS
Synopsys
$2.26B$13.5231.4434.963.2336.12%20.48%13.51%5/20/2025 (Estimated)
Technology Select Sector SPDR Fund stock logo
XLK
Technology Select Sector SPDR Fund
N/AN/A33.95N/AN/AN/AN/AN/A

Latest ANSS, SNPS, XLK, MDB, AFRM, CRSP, and PATH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/5/2025Q4 2025
MongoDB, Inc. stock logo
MDB
MongoDB
$0.64$0.19-$0.45$0.19$519.65 million$548.40 million
2/19/2025Q4 2024
ANSYS, Inc. stock logo
ANSS
ANSYS
$3.97$3.65-$0.32$3.21$864.46 million$882.17 million
2/11/2025Q4 2024
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
-$1.15-$0.44+$0.71-$0.44N/AN/A
2/6/2025Q2 2025
Affirm Holdings, Inc. stock logo
AFRM
Affirm
-$0.21$0.23+$0.44$0.23$799.56 millionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Affirm Holdings, Inc. stock logo
AFRM
Affirm
N/AN/AN/AN/AN/A
ANSYS, Inc. stock logo
ANSS
ANSYS
N/AN/AN/AN/AN/A
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
N/AN/AN/AN/AN/A
MongoDB, Inc. stock logo
MDB
MongoDB
N/AN/AN/AN/AN/A
UiPath Inc. stock logo
PATH
UiPath
N/AN/AN/AN/AN/A
Synopsys, Inc. stock logo
SNPS
Synopsys
N/AN/AN/AN/AN/A
Technology Select Sector SPDR Fund stock logo
XLK
Technology Select Sector SPDR Fund
$1.520.70%N/AN/AN/A

Latest ANSS, SNPS, XLK, MDB, AFRM, CRSP, and PATH Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
1/9/2025
Technology Select Sector SPDR Fund stock logo
XLK
Technology Select Sector SPDR Fund
$0.37493/24/20253/24/20253/26/2025
1/9/2025
Technology Select Sector SPDR Fund stock logo
XLK
Technology Select Sector SPDR Fund
$0.37493/24/20253/24/20253/26/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Affirm Holdings, Inc. stock logo
AFRM
Affirm
2.68
11.26
11.26
ANSYS, Inc. stock logo
ANSS
ANSYS
0.12
3.01
3.01
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
N/A
22.07
22.07
MongoDB, Inc. stock logo
MDB
MongoDB
N/A
1.70
1.70
UiPath Inc. stock logo
PATH
UiPath
N/A
3.13
3.13
Synopsys, Inc. stock logo
SNPS
Synopsys
N/A
2.44
2.30
Technology Select Sector SPDR Fund stock logo
XLK
Technology Select Sector SPDR Fund
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Affirm Holdings, Inc. stock logo
AFRM
Affirm
69.29%
ANSYS, Inc. stock logo
ANSS
ANSYS
92.39%
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
69.20%
MongoDB, Inc. stock logo
MDB
MongoDB
89.29%
UiPath Inc. stock logo
PATH
UiPath
62.50%
Synopsys, Inc. stock logo
SNPS
Synopsys
85.47%
Technology Select Sector SPDR Fund stock logo
XLK
Technology Select Sector SPDR Fund
N/A

Insider Ownership

CompanyInsider Ownership
Affirm Holdings, Inc. stock logo
AFRM
Affirm
12.41%
ANSYS, Inc. stock logo
ANSS
ANSYS
0.46%
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
4.10%
MongoDB, Inc. stock logo
MDB
MongoDB
3.60%
UiPath Inc. stock logo
PATH
UiPath
22.37%
Synopsys, Inc. stock logo
SNPS
Synopsys
0.62%
Technology Select Sector SPDR Fund stock logo
XLK
Technology Select Sector SPDR Fund
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Affirm Holdings, Inc. stock logo
AFRM
Affirm
2,006318.06 million278.59 millionOptionable
ANSYS, Inc. stock logo
ANSS
ANSYS
5,60087.65 million87.25 millionOptionable
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
47385.77 million82.26 millionOptionable
MongoDB, Inc. stock logo
MDB
MongoDB
3,54074.47 million71.79 millionOptionable
UiPath Inc. stock logo
PATH
UiPath
4,010549.60 million426.65 millionOptionable
Synopsys, Inc. stock logo
SNPS
Synopsys
19,000154.62 million153.56 millionOptionable
Technology Select Sector SPDR Fund stock logo
XLK
Technology Select Sector SPDR Fund
N/A310.56 millionN/ANot Optionable

Recent News About These Companies

XLK ETF Factor Report
XLK ETF Factor Report
U.S. Sector Leadership Shifts, Favoring Healthcare Stocks
XLK: What "Hidden" Bullish Breadth Tells Us About Tech
Best Tech Stocks to Watch in February 2025
Tech Rally Fuels Market Recovery: ASX set to rise
AI Rebound Fuels Tech Rally: ASX Poised for Gains

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Affirm stock logo

Affirm NASDAQ:AFRM

$50.98 -1.56 (-2.96%)
As of 02:37 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Affirm Holdings, Inc. operates a platform for digital and mobile-first commerce in the United States, Canada, and internationally. The company's platform includes point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. Its commerce platform, agreements with originating banks, and capital markets partners enables consumers to pay for a purchase over time with terms ranging up to 60 months. The company has active merchants covering small businesses, large enterprises, direct-to-consumer brands, brick-and-mortar stores, and companies with an omni-channel presence. Its merchants represent a range of industries, including sporting goods and outdoors, furniture and homewares, travel and ticketing, apparel, accessories, consumer electronics, and jewelry. Affirm Holdings, Inc. was founded in 2012 and is headquartered in San Francisco, California.

ANSYS stock logo

ANSYS NASDAQ:ANSS

$325.32 -0.42 (-0.13%)
As of 02:37 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ANSYS, Inc. develops and markets engineering simulation software and services for engineers, designers, researchers, and students in the United States, Japan, Germany, China, Hong Kong, South Korea, rest of Europe, the Middle East, Africa, and internationally. It offers structural analysis product suite that provides simulation tools for product design and optimization; the Ansys Mechanical product, an element analysis software; LS-DYNA solver for multiphysics simulation; and power analysis and optimization software suite. The company also offers electronics product suite that provides electromagnetic field simulation software for designing electronic and electromechanical products; Ansys High Frequency Structure Simulator product for radio frequency and microwave design; SCADE product suite, a solution for embedded software simulation, code production, and automated certification; fluids product suite that enables modeling of fluid flow and other related physical phenomena; Ansys Fluent computational fluid dynamics software package; Ansys RedHawk-SC for electronic design automation; Ansys Optics software; and mission-simulation, modeling, testing, and analysis software. In addition, it offers Ansys Granta MI system for materials information management; Ansys Granta Selector technology for materials selection and graphical analysis; CES EduPack product, a set of teaching resources; Granta Materials Data for Simulation; Ansys Lumerical product, a photonics simulation software solution; safety-certified embedded software solutions; Discovery product family for use in the simulation of product design; academic product suite for research and teaching settings. ANSYS, Inc. was founded in 1970 and is headquartered in Canonsburg, Pennsylvania.

CRISPR Therapeutics stock logo

CRISPR Therapeutics NASDAQ:CRSP

$40.93 -1.69 (-3.97%)
As of 02:37 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

CRISPR Therapeutics is a gene-editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene-editing technology that allows for precise, directed changes to genomic DNA. CRISPR Therapeutics has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic collaborations with companies including Bayer, Vertex Pharmaceuticals and ViaCyte, Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Cambridge, Massachusetts, and business offices in San Francisco, California and London, United Kingdom. For more information, please visit www.crisprtx.com.

MongoDB stock logo

MongoDB NASDAQ:MDB

$198.89 +1.41 (+0.71%)
As of 02:37 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

MongoDB, Inc., together with its subsidiaries, provides general purpose database platform worldwide. The company provides MongoDB Atlas, a hosted multi-cloud database-as-a-service solution; MongoDB Enterprise Advanced, a commercial database server for enterprise customers to run in the cloud, on-premises, or in a hybrid environment; and Community Server, a free-to-download version of its database, which includes the functionality that developers need to get started with MongoDB. It offers professional services comprising consulting and training. The company was formerly known as 10gen, Inc. and changed its name to MongoDB, Inc. in August 2013. MongoDB, Inc. was incorporated in 2007 and is headquartered in New York, New York.

UiPath stock logo

UiPath NYSE:PATH

$11.36 +0.16 (+1.38%)
As of 02:37 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

UiPath Inc. provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric. It serves banking and financial services, healthcare, insurance, public sectors, manufacturing, retail, and telecom industries. The company was founded in 2005 and is headquartered in New York, New York.

Synopsys stock logo

Synopsys NASDAQ:SNPS

$456.53 -1.24 (-0.27%)
As of 02:37 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Synopsys, Inc. provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions. It also provides intellectual property (IP) solutions for USB, PCI Express, DDR, Ethernet, MIPI, HDMI, and Bluetooth low energy applications; logic libraries and embedded memories; processor cores, software, and application-specific instruction-set processor tools for embedded applications; security IP solutions; IP solutions for automotive market; and system-on-chip (SoC) infrastructure IP, datapath and building block IP, and verification IP products, as well as mathematical and floating-point components, and Arm AMBA interconnect fabric and peripherals. In addition, the company offers HAPS FPGA-based prototyping systems; virtual prototyping solutions; and Platform Architect solutions for SoC architecture analysis and optimization, as well as optical products, and mechatronic simulations. Further, it provides security and quality testing products, managed services, programs and professional services, and training that enable its customers to detect and remediate security vulnerabilities, and defects in the software development lifecycle, as well as manufacturing solutions. Additionally, the company provides intelligent orchestration solution, software risk manager, and black duck software composition analysis tools. It serves electronics, financial services, automotive, medicine, energy, and industrial areas. The company was incorporated in 1986 and is headquartered in Sunnyvale, California.

Technology Select Sector SPDR Fund stock logo

Technology Select Sector SPDR Fund NYSEARCA:XLK

$218.08 +0.45 (+0.20%)
As of 02:37 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Sector SPDR Trust SBI Interest, formerly Technology Select Sector SPDR Fund, seeks to provide investment results that correspond to the price and yield performance of the Technology Select Sector of the S&P 500 Index (the Index). The Index includes companies primarily involved in industries, such as information technology (IT) consulting, semiconductor equipment and products, computers and peripherals, diversified telecommunication services and wireless telecommunication services.It utilizes a passive or indexing investment approach to invest in a portfolio of stocks that seek to replicate the Index. Sector SPDR Trust SBI Interest's investment advisor is SSgA Funds Management, Inc.